Favourable comparisons: comparators and the pharma industry
Clinical Trials Insight looks at ways to share strategies used to acquire blinded comparators for global trials, and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Dec 17
Clinical Trials Insight looks at ways to share strategies used to acquire blinded comparators for global trials, and…
14 Dec 17
Risk-based monitoring can promote more efficient data standardisation and speed up clinical trial timelines. Kerry Taylor-Smith speaks to…
14 Dec 17
The digital age is upon us, yet many clinical trials are still rooted in cumbersome paper-based procedures. An…
14 Dec 17
Dr Sanjay Sethi is a leading clinical trials manager in CPOD from the University of Buffalo, with a…
14 Dec 17
With sophisticated new technology making it more accessible than ever, real-world data has the potential to transform how…
14 Dec 17
Ambitious new EU guidance on transparency and disclosure aims to boost public trust, but it faces an industry-wide…
14 Dec 17
Trilogy Writing & Consulting’s Barry Drees and Lisa Chamberlain James explain how to communicate the results of clinical…
14 Dec 17
The overwhelming majority of pharmaceuticals fail when tested in humans, particularly in oncology, where 95% of drugs tested…
26 Jun 17
Correct packaging and labelling of investigational medicinal products are essential for guaranteeing regulatory compliance, minimising error-related costs and,…
26 Jun 17
Finding the right balance of funding in an age of shrinking budgets is a tightrope walk that could…